Enlibio，Your biological research partner ！
Xinqidi Biotech Co.,Ltd,Wuhan,China 2008-2022
R&D 14th year
ELISAs Human ELISA Kits‖Mouse ELISA Kits‖Rat ELISA Kits‖Other species ELISA kits,(96T*5, 96T*10, etc. Please contact us.)
Antibodies Primary Antibody‖Secondary Antibody‖Industrial Antibody development‖Antibody Development Services‖Antibody
――――――――――――――――――――――――――――――――――――――――――――――――――――――――――――
Product manual search
For the latest version of the manual, please contact Wuhan Xinqidi, sale@enlibio.com
Near shelf life ELISA Kit(negotiated price)
Human Vascular Endothelial Growth Factor D (VEGF-D)ELISA Kit
| The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma | [ Biological abstract ] | 2022-06-02 |
| Persister state-directed transitioning and vulnerability in melanoma | [ Biological abstract ] | 2022-06-02 |
| Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemog | [ Biological abstract ] | 2022-06-02 |
| The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers | [ Biological abstract ] | 2022-06-02 |
| Predicting cancer prognosis and drug response from the tumor microbiome | [ Biological abstract ] | 2022-05-31 |
| Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhib | [ Biological abstract ] | 2022-05-31 |
| Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche | [ Biological abstract ] | 2022-05-31 |
| Mutational signatures are markers of drug sensitivity of cancer cells | [ Biological abstract ] | 2022-05-31 |
Recombinant human TEX19 protein
|
|
|
|
|
